Moseley Investment Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-6,542
Closed -$217K 151
2022
Q2
$217K Sell
6,542
-1,533
-19% -$65.1K 0.15% 142
2022
Q1
$582K Sell
8,075
-131
-2% -$9.44K 0.31% 84
2021
Q4
$753K Buy
8,206
+148
+2% +$17.7K 0.34% 77
2021
Q3
$1.02M Buy
8,058
+158
+2% +$23K 0.51% 65
2021
Q2
$1.31M Buy
7,900
+779
+11% +$126K 0.65% 43
2021
Q1
$1.29M Buy
7,121
+2,013
+39% +$467K 0.72% 37
2020
Q4
$1.02M Buy
5,108
+1,527
+43% +$310K 0.59% 52
2020
Q3
$785K Buy
3,581
+2,138
+148% +$453K 0.56% 51
2020
Q2
$275K Buy
+1,443
New +$253K 0.23% 105

Other funds holding TDOC

Moseley Investment Management's TDOC Position: Q3 2022 in Review

Moseley Investment Management sold out of Teladoc Health (TDOC) in Q3 2022, closing a stake of 6,542 shares — an estimated $217K sold.

Moseley Investment Management first reported a position in TDOC in Q2 2020 and held it in 9 quarters. The position peaked at $1.31M in Q2 2021. 482 funds tracked by Wall St. Rank hold TDOC as of Q3 2022.

  • Moseley Investment Management reported no remaining Teladoc Health position as of Q3 2022 after selling out during the quarter.
  • Moseley Investment Management sold 6,542 Teladoc Health shares in Q3 2022, an estimated $217K.
  • Moseley Investment Management first reported a position in Teladoc Health in Q2 2020 and held it in 9 quarters.
  • Moseley Investment Management's Teladoc Health position peaked at $1.31M in Q2 2021.
  • 482 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2022.

Based on Moseley Investment Management's 13F filing for Q3 2022, filed 13 Oct 2022.